Profile
Michael Schaefer is currently the Director at 2cureX ApS since 2022.
Prior to this, he was the Co-Managing Director at Sysmex Europe SE and the Executive Vice President at Sysmex Corp.
He also served as an Independent Director at 2cureX AB from 2022 to 2024.
Michael Schaefer active positions
Companies | Position | Start |
---|---|---|
2cureX ApS
2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | Director/Board Member | 2021-12-31 |
Former positions of Michael Schaefer
Companies | Position | End |
---|---|---|
2CUREX AB | Director/Board Member | 2024-01-03 |
SYSMEX CORPORATION | Corporate Officer/Principal | - |
Sysmex Europe SE
Sysmex Europe SE Medical SpecialtiesHealth Technology Sysmex Europe GmbH designs and produces diagnostic solutions for medical laboratories. It offers diagnostics for haematology, urinalysis, coagulation, moleculat siagnostics, digital imaging, reagent production and veterinary solutions. It also provides solutions for optimized cancer management, sentinel lymph node analysis, and localization, patient care, faecal immunochemical test for haemoglobin, digital pathology and blood-based molecular testing. The company was founded in 1980 and is headquartered in Nordertstedt, Germany. | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
2CUREX AB | Health Technology |
SYSMEX CORPORATION | Health Technology |
Private companies | 2 |
---|---|
Sysmex Europe SE
Sysmex Europe SE Medical SpecialtiesHealth Technology Sysmex Europe GmbH designs and produces diagnostic solutions for medical laboratories. It offers diagnostics for haematology, urinalysis, coagulation, moleculat siagnostics, digital imaging, reagent production and veterinary solutions. It also provides solutions for optimized cancer management, sentinel lymph node analysis, and localization, patient care, faecal immunochemical test for haemoglobin, digital pathology and blood-based molecular testing. The company was founded in 1980 and is headquartered in Nordertstedt, Germany. | Health Technology |
2cureX ApS
2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | Health Technology |
- Stock Market
- Insiders
- Michael Schaefer